左卡尼丁治疗扩张型心肌病的Meta分析[EB/OL]
北京:中国科技论文在线
左室射血分数(LVEF)结果显示治疗终点的左卡尼丁组均高于对照组[WMD=3
70 ,95% CI(3
52~3
88)]
) 摘要: 摘要 目的:评价左卡尼丁治疗扩张型心肌病的有效性
心输出量(CO)结果显示治疗终点的左卡尼丁组均高于对照组[WMD=0
75,95% CI(0
61~0
89)]
At the end of treatment LCarnitine group improve CO higher than the control group, [WMD=0
75,95% CI(0
61~0
89)]
Conclusion: In the treatment of patients with dilated cardiomyopathy
左室舒张末期内径(LVEDD)结果显示治疗终点的左卡尼丁组均低于对照组[WMD=-3
18,95% CI(-4
53~-1
83)]
结果:纳入11篇文献
Meta结果显示:左卡尼丁组心功能改善情况优于对照组[OR=3